World TB Day 2004 Media Call with Eli Lilly on March 24, 2004 (9:15 a.m. EST)
New Data Offer Sobering Insights Into the Significance of Drug-Resistant Tuberculosis Renowned physician, leading global TB drug-development representative to join
New Data Offer Sobering Insights Into the Significance of Drug-Resistant Tuberculosis Renowned physician, leading global TB drug-development representative to join
Statement from Christine F. Sizemore, Ph.D., and Anthony S. Fauci, M.D., National Institute of Allergy and Infectious Diseases/ National Institutes
“TB kills two million people every year, but where is the sense of urgency that will secure resources and accelerate
WHAT: Press briefing by conference call from Global TB Partners Forum in New Delhi, India to outline a new Global
Regional increases in the prevalence of multidrug resistant tuberculosis (MDR-TB) underscore the need for developing new TB treatments, as reported
Cases of tuberculosis that are resistant to most of the drugs used to treat the disease are on the rise
Doctors need a new weapon in the fight against “super strains” of tuberculosis. A survey from the World Health Organization
There may be as many as 300,000 new cases of drug-resistant tuberculosis a year in the world, and 79 percent
LONDON – Drug-resistant strains of tuberculosis have reached troubling levels in Eastern Europe and Central Asia and could potentially worsen
If you think tuberculosis is a disease of the dim past, think again. More people will die of TB this